IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Unihealth Consultancy IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Healthcare sector. Unistone Capital Private is the merchant banker of Unihealth Consultancy IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th June 2023.
Unihealth Consultancy IPO posted revenues of Rs 46.03 crores and PAT of Rs 7.68 crores in FY25 on annualised basis.Financial results of Unihealth Consultancy IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Unihealth Consultancy IPO PAT Margin is 16.68%, ROCE (Return on Capital Employed) is 20.99% as per latest financial. The below table shows Unihealth Consultancy IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Unihealth Consultancy IPO is Rs 203.28 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Unihealth Consultancy IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Unihealth Consultancy IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Unihealth Consultancy IPO is ₹203.28 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Unihealth Consultancy IPO has a Price-to-Earnings (PE) ratio of 26.56 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Unihealth Consultancy IPO reported revenue of ₹46.03 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Unihealth Consultancy IPO provide insights into sales growth, market demand, and business scalability.
Unihealth Consultancy recorded an EBITDA of ₹ 15.91 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Unihealth Consultancy Profit After Tax (PAT) is ₹7.68 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 46.03 Cr.
EBITDA Margin:
34.56
%
Net Worth: ₹ 26.12 Cr.
Market Capitalisation:
₹ 203.28 Cr.
P/E:
26.56 times
P/BV: 2.46 times
EV/EBITDA: 15.12 times
Unihealth Consultancy operates in Healthcare and Healthcare Service Provider. The Issue is listed on NSE EMERGE in Sep, 2023. Unihealth Consultancy IPO size was 56.55 with Issue price of 132.00 .
Merchant Banker(s) of Unihealth Consultancy IPO: Unistone Capital Private Limited
Unihealth Consultancy IPO subscription was 18.22 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Unihealth Consultancy IPO listed at a listing price of 133.00 against the offer price of 132.00.
The current market price of Unihealth Consultancy is 141.00.
Why Us?
